Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | SPHK1 | Q9NYA1 | 4/20 | 0.37 |
| ▸ | SPHK2 | Q9NRA0 | 3/20 | 0.37 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10317758 | 1.00 | ALDH1A1 (0.54) | ALDH1A1TDP1LMNAEPHX1SMN1; SMN2 | |
| SCHEMBL29184226 | 1.00 | ALDH1A1 (0.54) | ALDH1A1TDP1LMNAEPHX1SMN1; SMN2 | |
| SCHEMBL28188909 | 0.98 | ALDH1A1 (0.50) | ALDH1A1TDP1LMNAEPHX1SMN1; SMN2 | |
| SCHEMBL11769136 | 0.94 | ALDH1A1 (0.50) | ALDH1A1TDP1LMNAEPHX1SMN1; SMN2 | |
| SCHEMBL11694889 | 0.92 | ALDH1A1 (0.53) | ALDH1A1TDP1LMNAEPHX1SMN1; SMN2 | |
| SCHEMBL29184180 | 0.89 | ALDH1A1 (0.57) | ALDH1A1TDP1LMNAEPHX1SMN1; SMN2 | |
| Water SCHEMBL19713221 | 0.88 | ALDH1A1 (0.45) | ALDH1A1TDP1LMNAEPHX1SMN1; SMN2 | |
| SCHEMBL11152905 | 0.87 | LMNA (0.47) | ALDH1A1TDP1LMNASPHK1SPHK2 | |
| SCHEMBL11149408 | 0.87 | LMNA (0.47) | ALDH1A1TDP1LMNASPHK1SPHK2 | |
| SCHEMBL11156504 | 0.87 | LMNA (0.47) | ALDH1A1TDP1LMNASPHK1SPHK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120076835-A | Multicomponent hydrogel gels and uses thereof | 高德美控股有限公司 | 2025-05-30 | — | — | CN | claimed |
| CN-116284886-B | Multiple crosslinked gel systems and products, methods of making and using the same | 上海其胜生物制剂有限公司 | 2024-11-29 | — | — | CN | claimed |
| CN-112041378-B | Injectable gel products | 高德美控股有限公司 | 2024-02-09 | — | — | CN | claimed |
| CN-117320762-A | Packaging solution | 博士伦爱尔兰有限公司 | 2023-12-29 | — | — | CN | claimed |
| CN-116284886-A | Multiple crosslinked gel systems and products, methods of making and using the same | 上海其胜生物制剂有限公司 | 2023-06-23 | — | — | CN | claimed |
| CN-122028891-A | Composition for conditioning keratin fibres | 莱雅公司 | 2026-05-12 | — | — | CN | disclosed |
| CN-120076835-A | Multicomponent hydrogel gels and uses thereof | 高德美控股有限公司 | 2025-05-30 | — | — | CN | disclosed |
| CN-119816577-A | Process for preparing a reaction product comprising a quaternary ammonium salt | 路博润公司 | 2025-04-11 | — | — | CN | disclosed |
| CN-116284886-B | Multiple crosslinked gel systems and products, methods of making and using the same | 上海其胜生物制剂有限公司 | 2024-11-29 | — | — | CN | disclosed |
| CN-118852478-A | Sulfated glycosaminoglycan biomaterials as proteoglycan mimics | 格莱克罗吉克斯公司 | 2024-10-29 | — | — | CN | disclosed |
| CN-118434459-A | Soft tissue augmentation using injectable, neutral pH soluble collagen-glycosaminoglycan compositions | 上海其胜生物制剂有限公司 | 2024-08-02 | — | — | CN | disclosed |
| CN-115697352-B | Sulfated glycosaminoglycan biomaterials as proteoglycan mimics | 格莱克罗吉克斯公司 | 2024-07-19 | — | — | CN | disclosed |
| EP-3505522-A1 | SURFACE TREATMENT METHOD, SURFACE TREATMENT AGENT, AND NOVEL COMPOUND | Mori, Kunio (JP) | 2019-07-03 | — | — | EP | disclosed |
| EP-2859962-B1 | SURFACE TREATMENT METHOD, SURFACE TREATMENT AGENT, AND NOVEL COMPOUND | MORI KUNIO (JP) | 2019-01-23 | — | — | EP | disclosed |
| US-20170334933-A1 | SURFACE TREATMENT AGENT AND NOVEL COMPOUND | Mori, Kunio (JP) | 2017-11-23 | — | — | US | disclosed |
| US-9790242-B2 | Surface treatment method, surface treatment agent, and novel compound | Mori, Kunio (JP) | 2017-10-17 | — | — | US | disclosed |
| CN-104349848-B | Surface treatment method, surface conditioning agent and new compound | Sen Bangfu (JP) | 2016-01-20 | — | — | CN | disclosed |
| US-20150152124-A1 | SURFACE TREATMENT METHOD, SURFACE TREATMENT AGENT, AND NOVEL COMPOUND | Mori, Kunio (JP) | 2015-06-04 | — | — | US | disclosed |
| EP-2859962-A1 | SURFACE TREATMENT METHOD, SURFACE TREATMENT AGENT, AND NOVEL COMPOUND | Mori, Kunio (JP) | 2015-04-15 | — | — | EP | disclosed |
| CN-104349848-A | Surface treatment method, surface treatment agent, and novel compound | MORI KUNIO | 2015-02-11 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150152124-A1 | SURFACE TREATMENT METHOD, SURFACE TREATMENT AGENT, AND NOVEL COMPOUND | EPCAM, ITGAM, MET | ALDH1A1 963/4885TDP1 4407/4885LMNA 2695/4885 |
| US-20170334933-A1 | SURFACE TREATMENT AGENT AND NOVEL COMPOUND | EPCAM, MET, ITGAM | ALDH1A1 841/4885TDP1 4397/4885LMNA 1873/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.